Healthcare provider profile · identity verified

Jayme Swanson

Family Practice · PROSSER, WA · NPI 1033565726

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	462	128
Levothyroxine Sodium	Levothyroxine Sodium	355	75
Lisinopril	Lisinopril	256	68
Losartan Potassium	Losartan Potassium	250	70
Omeprazole	Omeprazole	178	41
Amlodipine Besylate	Amlodipine Besylate	154	40
Gabapentin	Gabapentin	145	30
Hydrochlorothiazide	Hydrochlorothiazide	133	41
Trazodone Hcl	Trazodone Hcl	133	31
Albuterol Sulfate Hfa	Albuterol Sulfate	130	39
Ozempic	Semaglutide	116	20
Metoprolol Succinate	Metoprolol Succinate	111	29
Tamsulosin Hcl	Tamsulosin Hcl	108	32
Furosemide	Furosemide	106	25
Metformin Hcl	Metformin Hcl	104	32
Rosuvastatin Calcium	Rosuvastatin Calcium	102	30
Pravastatin Sodium	Pravastatin Sodium	101	18
Farxiga	Dapagliflozin Propanediol	96	17
Simvastatin	Simvastatin	89	22
Sertraline Hcl	Sertraline Hcl	85	19
Tizanidine Hcl	Tizanidine Hcl	84	31
Potassium Chloride	Potassium Chloride	80	14
Duloxetine Hcl	Duloxetine Hcl	76	15
Metoprolol Tartrate	Metoprolol Tartrate	76	18
Meloxicam	Meloxicam	73	15
Citalopram Hbr	Citalopram Hydrobromide	72	20
Escitalopram Oxalate	Escitalopram Oxalate	67	16
Pantoprazole Sodium	Pantoprazole Sodium	62	11
Eliquis	Apixaban	60	12
Carvedilol	Carvedilol	57	suppressed
Famotidine	Famotidine	57	14
Pregabalin	Pregabalin	53	13
Hydroxyzine Hcl	Hydroxyzine Hcl	52	17
Clopidogrel	Clopidogrel Bisulfate	51	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	13
Oxybutynin Chloride Er	Oxybutynin Chloride	47	suppressed
Spironolactone	Spironolactone	47	13
Allopurinol	Allopurinol	46	11
Fluticasone Propionate	Fluticasone Propionate	46	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	46	13
Baclofen	Baclofen	45	suppressed
Montelukast Sodium	Montelukast Sodium	45	suppressed
Januvia	Sitagliptin Phosphate	44	11
Lorazepam	Lorazepam	44	15
Cephalexin	Cephalexin	42	29
Warfarin Sodium	Warfarin Sodium	42	11
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Lovastatin	Lovastatin	39	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Ropinirole Hcl	Ropinirole Hcl	37	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	37	28
Mounjaro	Tirzepatide	36	suppressed
Nifedipine Er	Nifedipine	35	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	35	suppressed
Rybelsus	Semaglutide	34	suppressed
Jardiance	Empagliflozin	32	suppressed
Chlorthalidone	Chlorthalidone	31	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Digoxin	Digoxin	30	suppressed
Metformin Hcl Er	Metformin Hcl	30	11
Myrbetriq	Mirabegron	30	suppressed
Tramadol Hcl	Tramadol Hcl	30	12
Zolpidem Tartrate	Zolpidem Tartrate	30	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Trulicity	Dulaglutide	29	suppressed
Xarelto	Rivaroxaban	29	suppressed
Buspirone Hcl	Buspirone Hcl	28	suppressed
Estradiol	Estradiol	28	11
Alendronate Sodium	Alendronate Sodium	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Glipizide Er	Glipizide	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Prednisone	Prednisone	23	21
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	11
Torsemide	Torsemide	23	suppressed
Benazepril Hcl	Benazepril Hcl	22	suppressed
Glipizide	Glipizide	22	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	21	suppressed
Gemtesa	Vibegron	21	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	18
Aripiprazole	Aripiprazole	20	suppressed
Ibandronate Sodium	Ibandronate Sodium	20	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	20	suppressed
Azithromycin	Azithromycin	19	17
Bumetanide	Bumetanide	19	suppressed
Dilt-Xr	Diltiazem Hcl	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Ondansetron Odt	Ondansetron	18	13
Bupropion Xl	Bupropion Hcl	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Topiramate	Topiramate	14	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	suppressed
Finasteride	Finasteride	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Belsomra	Suvorexant	12	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Bydureon Bcise	Exenatide Microspheres	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error